Project Details
Description
A Phase I Study of Neihulizumab (AbGn-168H) in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease (sr-aGvHD)
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/18 → 3/1/24 |
Funding
- ABGENOMICS INTERNATIONAL INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.